1. Home
  2. BLCO vs UPST Comparison

BLCO vs UPST Comparison

Compare BLCO & UPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLCO
  • UPST
  • Stock Information
  • Founded
  • BLCO 1853
  • UPST 2012
  • Country
  • BLCO Canada
  • UPST United States
  • Employees
  • BLCO N/A
  • UPST N/A
  • Industry
  • BLCO Ophthalmic Goods
  • UPST Finance: Consumer Services
  • Sector
  • BLCO Health Care
  • UPST Finance
  • Exchange
  • BLCO Nasdaq
  • UPST Nasdaq
  • Market Cap
  • BLCO 7.0B
  • UPST 6.8B
  • IPO Year
  • BLCO 2022
  • UPST 2020
  • Fundamental
  • Price
  • BLCO $18.02
  • UPST $68.40
  • Analyst Decision
  • BLCO Buy
  • UPST Buy
  • Analyst Count
  • BLCO 12
  • UPST 11
  • Target Price
  • BLCO $20.91
  • UPST $65.44
  • AVG Volume (30 Days)
  • BLCO 524.8K
  • UPST 6.8M
  • Earning Date
  • BLCO 10-30-2024
  • UPST 02-11-2025
  • Dividend Yield
  • BLCO N/A
  • UPST N/A
  • EPS Growth
  • BLCO N/A
  • UPST N/A
  • EPS
  • BLCO N/A
  • UPST N/A
  • Revenue
  • BLCO $4,684,000,000.00
  • UPST $604,944,000.00
  • Revenue This Year
  • BLCO $17.39
  • UPST $11.39
  • Revenue Next Year
  • BLCO $6.18
  • UPST $34.31
  • P/E Ratio
  • BLCO N/A
  • UPST N/A
  • Revenue Growth
  • BLCO 18.01
  • UPST 10.89
  • 52 Week Low
  • BLCO $13.16
  • UPST $20.60
  • 52 Week High
  • BLCO $21.69
  • UPST $88.95
  • Technical
  • Relative Strength Index (RSI)
  • BLCO 36.81
  • UPST 45.54
  • Support Level
  • BLCO $17.71
  • UPST $73.44
  • Resistance Level
  • BLCO $18.99
  • UPST $86.99
  • Average True Range (ATR)
  • BLCO 0.52
  • UPST 6.29
  • MACD
  • BLCO -0.17
  • UPST -1.78
  • Stochastic Oscillator
  • BLCO 10.17
  • UPST 12.18

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

About UPST Upstart Holdings Inc. Common stock

Upstart Holdings Inc provides credit services. The company provides a proprietary, cloud-based, artificial intelligence lending platform. The platform aggregates consumer demand for loans and connects it to the network of Upstart AI-enabled bank partners. Upstart's platform includes personal loans, automotive retail and refinance loans, home equity lines of credit and small dollar loans.

Share on Social Networks: